ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,639Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 1000

$1.01M Total Retail Price of All Prescriptions

Rank: 51 out of 1000

662 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 662 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 662 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 11,591 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 1,018 730 1 3
HYDROCODONE-ACETAMINOPHEN 882 358 S3 2 1
LISINOPRIL 745 510 3 5
OMEPRAZOLE 601 400 4 2
FUROSEMIDE 514 402 5 7
LEVOTHYROXINE SODIUM 456 308 6 4
METFORMIN HCL 374 245 7 8
AMLODIPINE BESYLATE 364 304 8 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 356 219 9 20
TRAMADOL HCL 312 154 10 13
CITALOPRAM HBR 279 168 11 17
METOPROLOL TARTRATE 263 190 12 19
ATORVASTATIN CALCIUM 254 173 13 18
HYDROCHLOROTHIAZIDE 241 210 14 9
LOSARTAN POTASSIUM 231 168 15 25
CARVEDILOL 218 184 16 15
ATENOLOL 211 163 17 24
CRESTOR 201 137 18 30
TRAZODONE HCL 192 120 19 29
WARFARIN SODIUM 181 126 20 22
PANTOPRAZOLE SODIUM 180 125 21 28
MELOXICAM 177 140 22 14
RAMIPRIL 170 139 23 77
AMLODIPINE BESYLATE-BENAZEPRIL 167 101 24 59
TERAZOSIN HCL 166 130 25 150
CARISOPRODOL 163 28 R 26 72
LYRICA 160 91 27 47
ESCITALOPRAM OXALATE 152 84 28 60
ALLOPURINOL 148 107 29 31
TAMSULOSIN HCL 147 77 30 33
KLOR-CON 8 142 102 31 217
ZOLPIDEM TARTRATE 141 89 32 16
AMITRIPTYLINE HCL 136 63 R 33 45
NEXIUM 131 76 34 23
CIPROFLOXACIN HCL 129 82 35 46
QUINAPRIL HCL 127 105 36 117
OXYCONTIN 124 55 S2 37 166
CLOPIDOGREL 123 103 38 35
GABAPENTIN 118 76 39 11
GLIPIZIDE 115 84 40 62
CYCLOBENZAPRINE HCL 111 42 R 41 39
JANUVIA 109 65 42 85
GLIPIZIDE ER 108 90 43 106
NIASPAN 107 68 44 172
POTASSIUM CHLORIDE 105 64 45 10
AZITHROMYCIN 104 57 46 36
CLONIDINE HCL 104 62 46 27
SPIRIVA 100 74 48 64
ALENDRONATE SODIUM 99 96 49 57
METFORMIN HCL ER 98 64 50 44
LOSARTAN-HYDROCHLOROTHIAZIDE 93 52 51 38
JANUMET 92 76 52 195
INSULIN SYRINGE 91 51 53 93
PLAVIX 89 72 54 49
FLUOXETINE HCL 88 32 55 51
HUMULIN 70-30 87 57 56 131
MORPHINE SULFATE ER 86 0 S2 57 143
CYMBALTA 85 26 58 53
PROAIR HFA 83 42 59 50
METOPROLOL SUCCINATE 81 72 60 21
HYDROXYZINE HCL 80 35 R 61 153
GLIMEPIRIDE 80 80 61 34
DILTIAZEM 24HR ER 78 51 63 189
ZETIA 78 48 63 95
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 43 63 70
NAPROXEN 77 56 66 81
LANTUS 75 37 67 68
OXYCODONE HCL-ACETAMINOPHEN 70 25 S2 68 138
RANITIDINE HCL 68 53 69 37
SYNTHROID 68 46 69 91
ESTRADIOL 67 25 R 71 114
DILTIAZEM ER 65 52 72 146
DONEPEZIL HCL 64 54 73 32
PRAVASTATIN SODIUM 64 27 73 12
LOVASTATIN 63 44 75 41
SERTRALINE HCL 60 29 76 26
PHENYTOIN SODIUM EXTENDED 59 22 77 115
TRIAMTERENE-HCTZ 56 35 78 48
FLUTICASONE PROPIONATE 55 28 79 40
BUPROPION HCL SR 54 26 80 183
VENLAFAXINE HCL ER 54 0 80 124
KLOR-CON 10 54 47 80 104
DILTIAZEM 24HR CD 53 44 83 136
HYDRALAZINE HCL 53 37 83 74
OXYCODONE-ACETAMINOPHEN 51 0 S2 85 202
LEVETIRACETAM 51 0 85 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.